Graniforce 1mg Injection Ampoule

babies: not applicable. lactating mothers: graniforce injection is probably safe to use during breastfeeding. limited human data suggests that the drug does not represent any significant risk to the baby. pregnancy: graniforce injection is generally considered safe to use during pregnancy.
animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies. driving: graniforce injection does not usually affect your ability to drive. alcohol: it is not known whether it is safe to consume alcohol with graniforce injection. please consult your doctor. kidney: graniforce injection is probably safe to use in patients with kidney disease.
limited data available suggests that you may not need a dose adjustment of graniforce injection in these patients. please consult your doctor. liver: graniforce injection is probably safe to use in patients with liver disease.
limited data available suggests that you may not need a dose adjustment of graniforce injection in these patients. please consult your doctor..

injection site pain constipation diarrhoea headache weakness insomnia.

graniforce injection is an antiemetic. it blocks the effects of a chemical messenger (serotonin) in the brain that cause nausea and vomiting during cancer treatment (chemotherapy) or after surgery..

consult your doctor immediately if you missed the dose of graniforce injection..

• you have been prescribed graniforce injection to prevent nausea and vomiting caused by surgery or from chemotherapy and radiation therapy • graniforce is given as an injection under medical supervision • avoid heavy meals and try to eat small, nutritious snacks throughout the day. also, drink water regularly to avoid dehydration • do not stop the medicine unless told by the doctor..

contraindicated • graniforce + apomorphine: concurrent use may lead to profound hypotension and altered consciousness • graniforce + bepridil: concurrent use may lead to increased qt-interval prolongation • graniforce + fluconazole: concurrent use may lead to increased qt-interval prolongation • graniforce + mesoridazine: concurrent use may lead to increased qt-interval prolongation • graniforce + dronedarone: concurrent use may lead to increased qt-interval prolongation • graniforce + saquinavir: concurrent use may lead to increased qt-interval prolongation major • graniforce + alfentanil: concurrent use may lead to increased risk of serotonin syndrome • graniforce + alfuzosin: concurrent use may lead to increased qt-interval prolongation • graniforce + amisulpride: concurrent use may lead to increased risk of serious ventricular arrhythmias such as torsade’s de pointes • graniforce + amitriptyline: concurrent use may lead to increased risk of serotonin syndrome and qt-interval prolongation.